U.S. flag

An official website of the United States government

NM_182641.4(BPTF):c.52_61del (p.Glu18fs) AND Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 19, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001254180.2

Allele description [Variation Report for NM_182641.4(BPTF):c.52_61del (p.Glu18fs)]

NM_182641.4(BPTF):c.52_61del (p.Glu18fs)

Gene:
BPTF:bromodomain PHD finger transcription factor [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
17q24.2
Genomic location:
Preferred name:
NM_182641.4(BPTF):c.52_61del (p.Glu18fs)
HGVS:
  • NC_000017.11:g.67825776_67825785del
  • NG_052828.1:g.5260_5269del
  • NM_004459.7:c.52_61del
  • NM_182641.4:c.52_61delMANE SELECT
  • NP_004450.3:p.Glu18fs
  • NP_872579.2:p.Glu18fs
  • NC_000017.10:g.65821892_65821901del
  • p.Glu18Profs*44
Protein change:
E18fs
Links:
dbSNP: rs2055932118
NCBI 1000 Genomes Browser:
rs2055932118
Molecular consequence:
  • NM_004459.7:c.52_61del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_182641.4:c.52_61del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies
Identifiers:
MONDO: MONDO:0060596; MedGen: C4540327; OMIM: 617755

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001427229Clinical Genomics Laboratory, Stanford Medicine
no assertion criteria provided
Pathogenic
(Mar 19, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Clinical Genomics Laboratory, Stanford Medicine, SCV001427229.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providedclinical testingnot provided

Description

The p.Glu18Profs*44 variant in the BPTF gene was identified de novo in this individual, but has not been previously reported in association with disease. This variant was absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). However, the ability to detect this type of variation may be limited. The p.Glu18Profs*44 variant results in a 10 bp deletion, which causes a shift in the protein reading frame, leading to a premature termination codon 44 amino acids downstream. The premature termination codon is in exon 1 of 28 coding exons, and is therefore predicted to undergo nonsense-mediated decay resulting in a truncated or absent protein. Heterozygous loss of function is an established mechanism of disease for the BPTF gene. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, there is sufficient evidence to classify the p.Glu18Profs*44 variant as pathogenic for autosomal dominant BPTFassociated neurodevelopmental disorder based on the information above. [ACMG evidence codes used: PVS1; PM2; PS2_Supporting]

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jul 7, 2024